Status:
UNKNOWN
Hyperimmune Colostrum and Oral Mucositis
Lead Sponsor:
Tel-Aviv Sourasky Medical Center
Conditions:
Head and Neck Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
To study the effect of daily intake of hyperimmune colostrum on prevention and treatment of oral mucositis in patients with head and neck cancer undergoing high-dose radiation.
Eligibility Criteria
Inclusion
- Patients with: naso-pharynx, oral cavity, oro-pharynx and advanced localized laryngeal cancer.
Exclusion
- Other tumors
- Non-epithelial tumors
- Pregnancy
- Poor functional status
Key Trial Info
Start Date :
July 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2009
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00699569
Start Date
July 1 2008
End Date
July 1 2009
Last Update
July 23 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sourasky Medical Center
Tel Aviv, Israel